T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression-Reference-Cited by-同舟云学术

T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression

Published:2019-06-07 Issue:9 Volume:8 Page:e1621676
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kegler Alexandra¹,Koristka Stefanie¹,Bergmann Ralf¹^ORCID,Berndt Nicole¹,Arndt Claudia¹,Feldmann Anja¹,Hoffmann Anja¹,Bornhäuser Martin²³⁴,Schmitz Marc³⁴⁵,Bachmann Michael P.¹³⁴⁶

Affiliation:

1. Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany

2. Medical Clinic and Policlinic I, University Hospital `Carl Gustav Carus’ Technische Universität Dresden, Dresden, Germany

3. National Center for Tumor Diseases (NCT), partner site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany

4. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), National Center for Tumor Diseases, Partner site Dresden (NCT), Heidelberg, Germany

5. Institute of Immunology, Medical Faculty `Carl Gustav Carus’ Technische Universität Dresden, Dresden, Germany

6. Tumor Immunology, UniversityCancerCenter (UCC) `Carl Gustav Carus’ Technische Universität Dresden, Dresden, Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2019.1621676

Reference68 articles.

1. Chimeric antigen receptor T-cell therapies for lymphoma

2. Therapeutic T cell engineering

3. Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

4. Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy

5. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in CAR-based therapy for kidney disease;Frontiers in Immunology;2024-08-20

2. Unlocking the potential of Tregs: innovations in CAR technology;Frontiers in Molecular Biosciences;2023-10-12

3. CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them;HemaSphere;2023-08-18

4. A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells;Frontiers in Immunology;2023-06-13

5. Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe;Cancers;2022-10-30